Quantum BioPharma Ltd. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-12-23: Form 6-K; Period of report 2025-12-23; Description FORM 6-K; Document f6k_122325.htm.
- 2025-12-22: Form 6-K; Period of report 2025-12-22; Description 6-K; Document g085049_6k.htm.
- 2025-12-22: Form 6-K; Period of report 2025-12-22; Description FORM 6-K; Document f6k_122125.htm.
- 2025-12-22: Form 6-K; Period of report 2025-12-19; Description FORM 6-K; Document f6k_121925.htm.